loadpatents
name:-0.31699085235596
name:-0.10220408439636
name:-0.25344181060791
Wu; Yong-Jin Patent Filings

Wu; Yong-Jin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Yong-Jin.The latest application filed is for "triazolopyridinyl compounds as kinase inhibitors".

Company Profile
7.39.47
  • Wu; Yong-Jin - Madison CT
  • Wu; Yong Jin - Jian'ou CN
  • Wu; Yong Jin - Jian'ou City CN
  • Wu; Yong-Jin - Princeton NJ
  • Wu, Yong-Jin - East Lyme CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Triazolopyridinyl Compounds As Kinase Inhibitors
App 20220119388 - Luo; Guanglin ;   et al.
2022-04-21
Touch panel and device thereof
Grant 11,294,518 - Liu , et al. April 5, 2
2022-04-05
Touch Panel And Device Thereof
App 20220083170 - Liu; Qi Bin ;   et al.
2022-03-17
Acyl sulfonamide NaV1.7 inhibitors
Grant 10,836,758 - Wu , et al. November 17, 2
2020-11-17
Aminopyrrolotriazines As Kinase Inhibitors
App 20200347071 - Watterson; Scott Hunter ;   et al.
2020-11-05
Acyl Sulfonamide Nav1.7 Inhibitors
App 20200048240 - WU; Yong-Jin ;   et al.
2020-02-13
Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 10,526,323 - Conn , et al. J
2020-01-07
Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
Grant 10,227,343 - Conn , et al.
2019-03-12
Indazole And Azaindazole Substituted Compounds As Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction
App 20180022746 - Conn; P. Jeffrey ;   et al.
2018-01-25
Isoquiniline And Napthalene-substituted Compounds As Mglur4 Allosteric Potentiators, Compositions, And Methods Of Treating Neurological Dysfunction
App 20180022745 - Conn; P. Jeffrey ;   et al.
2018-01-25
4,6-diarylaminothiazines as BACE1 inhibitors and their use for the reduction of beta-amyloid production
Grant 9,475,784 - Wu , et al. October 25, 2
2016-10-25
Compounds For The Reduction Of Beta-amyloid Production
App 20150336975 - Boy; Kenneth M. ;   et al.
2015-11-26
4,6-diarylaminothiazines As Bace1 Inhibitors And Their Use For The Reduction Of Beta-amyloid Production
App 20150329506 - Wu; Yong-Jin ;   et al.
2015-11-19
Compounds For The Reduction Of Beta-amyloid Production
App 20150152089 - Boy; Kenneth M. ;   et al.
2015-06-04
Compounds for the reduction of .beta.-amyloid production
Grant 8,710,061 - Boy , et al. April 29, 2
2014-04-29
Compounds for the reduction of beta-amyloid production
Grant 8,637,523 - Boy , et al. January 28, 2
2014-01-28
Compounds for the reduction of beta-amyloid production
Grant 8,637,525 - Boy , et al. January 28, 2
2014-01-28
Compounds for the reduction of beta-amyloid production
Grant 8,604,024 - Thompson, III , et al. December 10, 2
2013-12-10
Compounds for the reduction of beta-amyloid production
Grant 8,598,161 - Wu December 3, 2
2013-12-03
Compounds for the reduction of .beta.-amyloid production
Grant 8,486,952 - Boy , et al. July 16, 2
2013-07-16
Compounds For The Reduction Of Beta-amyloid Production
App 20130178462 - Boy; Kenneth M. ;   et al.
2013-07-11
Compounds For The Reduction Of Beta-amyloid Production
App 20130131051 - THOMPSON, III; LORIN A. ;   et al.
2013-05-23
Compounds For The Reduction Of Beta-amyloid Production
App 20130131049 - Wu; Yong-Jin
2013-05-23
Compounds For The Reduction Of Beta-amyloid Production
App 20130030011 - BOY; KENNETH M. ;   et al.
2013-01-31
Bicyclic compounds for the reduction of beta-amyloid production
Grant 8,349,880 - Marcin , et al. January 8, 2
2013-01-08
Compounds For The Reduction Of Beta-amyloid Production
App 20120184565 - Boy; Kenneth M. ;   et al.
2012-07-19
Compounds For The Reduction Of Beta-amyloid Production
App 20120028994 - Boy; Kenneth M. ;   et al.
2012-02-02
Compounds For The Reduction Of Beta-amyloid Production
App 20110212937 - Boy; Kenneth M. ;   et al.
2011-09-01
Bicyclic Compounds for the Reduction of Beta-Amyloid Production
App 20110015175 - Marcin; Lawrence R. ;   et al.
2011-01-20
Diaminopropane derived macrocycles as inhibitors of .beta. amyloid production
Grant 7,772,221 - Marcin , et al. August 10, 2
2010-08-10
Oxime-containing macrocyclic acyl guanidines as .beta.-secretase inhibitors
Grant 7,678,784 - Wu , et al. March 16, 2
2010-03-16
Cycloalkylamine derivatives as NK-1/SSRI antagonists
Grant 7,494,986 - Wu , et al. February 24, 2
2009-02-24
Phenylcarboxyamides as beta-secretase inhibitors
Grant 7,476,764 - Wu , et al. January 13, 2
2009-01-13
Diaminopropane Derived Macrocycles As Inhibitors Of Beta Amyloid Production
App 20080194535 - Marcin; Lawrence R. ;   et al.
2008-08-14
Oxime-containing acyl guanidines as beta-secretase inhibitors
Grant 7,390,925 - Wu , et al. June 24, 2
2008-06-24
Oxime-containing Macrocyclic Acyl Guanidines As Beta-secretase Inhibitors
App 20080139523 - Wu; Yong-Jin ;   et al.
2008-06-12
Oxime-Containing Acyl Guanidines as Beta-Secretase Inhibitors
App 20070232581 - Wu; Yong-Jin ;   et al.
2007-10-04
Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
Grant 7,276,631 - Wu , et al. October 2, 2
2007-10-02
2-aryl thiazole derivatives as KCNQ modulators
Grant 7,273,866 - Boy , et al. September 25, 2
2007-09-25
Novel phenylcarboxyamides as beta-secretase inhibitors
App 20070032470 - Wu; Yong-Jin ;   et al.
2007-02-08
Arylcyclopropylcarboxylic amides as potassium channel openers
Grant 7,144,881 - Wu , et al. December 5, 2
2006-12-05
Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
Grant 7,138,423 - Wu , et al. November 21, 2
2006-11-21
3-Heterocyclic benzylamide derivatives as potassium channel openers
Grant 7,135,472 - Wu , et al. November 14, 2
2006-11-14
Homopiperidine derivatives as NK-1 antagonists
Grant 7,098,203 - Wu , et al. August 29, 2
2006-08-29
3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers
Grant 7,087,609 - Wu , et al. August 8, 2
2006-08-08
1-aryl-2-hydroxyethyl amides as potassium channel openers
Grant 7,045,551 - Wu , et al. May 16, 2
2006-05-16
Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
App 20060019944 - Wu; Yong-Jin ;   et al.
2006-01-26
Cycloalkylamine derivatives as NK-1/SSRI antagonists
App 20060019992 - Wu; Yong-Jin ;   et al.
2006-01-26
Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
App 20060020011 - Wu; Yong-Jin ;   et al.
2006-01-26
Homopiperidine derivatives as NK-1 antagonists
App 20060019943 - Wu; Yong-Jin ;   et al.
2006-01-26
Aminoalkyl thiazole derivatives as KCNQ modulators
Grant 6,933,308 - Boy , et al. August 23, 2
2005-08-23
Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
Grant 6,900,210 - Wu , et al. May 31, 2
2005-05-31
Pyridopyrimidine derivatives as 5-HT6 antagonists
Grant 6,875,771 - Wu , et al. April 5, 2
2005-04-05
Cinnamide derivatives as KCNQ potassium channel modulators
Grant 6,831,080 - Wu , et al. December 14, 2
2004-12-14
Erythromycin derivatives
Grant 6,825,171 - Wu November 30, 2
2004-11-30
13-methyl erythromycin derivatives
Grant 6,777,543 - Wu , et al. August 17, 2
2004-08-17
2-aryl thiazole derivatives as KCNQ modulators
App 20040147401 - Boy, Kenneth M. ;   et al.
2004-07-29
Aminoalkyl thiazole derivatives as KCNQ modulators
App 20040138268 - Boy, Kenneth M. ;   et al.
2004-07-15
1-aryl-2-hydroxyethyl amides as potassium channel openers
App 20040122007 - Wu, Yong-Jin ;   et al.
2004-06-24
3-(Pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers
App 20040110765 - Wu, Yong-Jin ;   et al.
2004-06-10
Arylcyclopropylcarboxylic amides as potassium channel openers
App 20040110754 - Wu, Yong-Jin ;   et al.
2004-06-10
3-Heterocyclic benzylamide derivatives as potassium channel openers
App 20040106621 - Wu, Yong-Jin ;   et al.
2004-06-03
Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
App 20040102449 - Wu, Yong-Jin ;   et al.
2004-05-27
Novel erythromycin derivatives
App 20040067897 - Wu, Yong-Jin
2004-04-08
Pyridopyrimidine derivatives as 5-HT6 antagonists
App 20040019064 - Wu, Yong-Jin ;   et al.
2004-01-29
Carbamate and carbazate ketolide antibiotics
Grant 6,664,238 - Su , et al. December 16, 2
2003-12-16
13-Methyl erythromycin derivatives
App 20030229031 - Wu, Yong-Jin ;   et al.
2003-12-11
Cinnamide derivatives as KCNQ potassium channel modulators
App 20030166650 - Wu, Yong-Jin ;   et al.
2003-09-04
13-Methyl erythromycin derivatives
App 20030100518 - Wu, Yong-Jin ;   et al.
2003-05-29
Erythromycin a derivatives
App 20030100742 - Kaneko, Takushi ;   et al.
2003-05-29
9-oxime erythromycin derivatives
App 20020151507 - Wu, Yong-Jin
2002-10-17
Tricyclic erythromycin derivatives
App 20020077302 - Wu, Yong-Jin
2002-06-20
9-amino-3-oxo erythromycin derivatives
App 20020061857 - Wu, Yong-Jin
2002-05-23
Novel tricyclic erythromycin derivatives
App 20020061856 - Wu, Yong-Jin
2002-05-23
9-oxime Erythromycin Derivatives
App 20020025937 - WU, YONG-JIN
2002-02-28
9a,11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin
App 20010016574 - Wu, Yong-Jin
2001-08-23
Erythromycin derivatives
Grant 6,262,030 - Wu , et al. July 17, 2
2001-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed